Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Palomid 529 (CAS 914913-88-5)

0.0(0)
Write a reviewAsk a question

Alternate Names:
P529; 3-(4-methoxybenzyloxy)-8-(1-hydroxyethyl)-2-methoxy-6H-benzo[c]chromen-6-one
Application:
Palomid 529 is a novel PI3K/Akt/mTOR inhibitor with a GI50 of <35 µM in the NCI-60 cell lines panel
CAS Number:
914913-88-5
Purity:
≥98%
Molecular Weight:
406.43
Molecular Formula:
C24H22O6
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Palomid 529 is a novel inhibitor of PI3K, Akt, and mTOR. Palomid 529 is an inhibitor of the TORC1 and TORC2 complexes and inhibits Akt signaling and mTOR signaling in similar ways in vasculature and tumor. Palomid 529 is an inhibitor of tumor growth, angiogenesis, and vascular permeability. Palomid 529 has the additional benefit of blocking pAktS473 signaling consistent with blocking TORC2 in all cells and thus bypassing feedback loops that lead to increased Akt signaling in some tumor cells. Palomid 529 inhibited both VEGF-driven (IC50 = 20 nM) and bFGF-driven (IC50 = 30 nM) endothelial cell proliferation and retained the ability to induce endothelial cell apoptosis. Palomid 529 significantly enhanced the antiproliferative effect of radiation in prostate cancer cells.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Palomid 529, 10 mg

sc-364563
10 mg
$300.00

Palomid 529, 50 mg

sc-364563A
50 mg
$1000.00